JMP Securities reiterated its Market Outperform rating on Protagonist Therapeutics (NASDAQ:PTGX) with a steady price target of $58.00, representing significant upside potential from the current price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback